Observing the positioning of glaucoma microstents after surgery
Post-operative Anterior Segment OCT Evaluation of Trabecular Microstent Positioning and the Impact on Intraocular Pressure
This study looks at how well glaucoma microstents are positioned after surgery in adults who also had cataract surgery, to see if their placement affects eye pressure over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 116 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | University of Utah Academic / other |
| Locations | 1 site (Murray, Utah) |
| Trial ID | NCT06666751 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the long-term outcomes of glaucoma microstent surgery in adults who have also undergone cataract surgery within the last two years. Participants will undergo a one-time eye exam and Optical Coherence Tomography (OCT) to assess the positioning of microstents and the dilation of Schlemm's canal. Researchers will analyze medical records to gather data on surgeon experience and the effectiveness of the surgery based on changes in intraocular pressure. The study seeks to determine the frequency of microstent mispositioning and its impact on intraocular pressure post-surgery.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have undergone Hydrus microstent or iStent Inject placement at the Moran Eye Center.
Not a fit: Patients who have had their stent removed or have a history of anterior segment trauma or anatomical alterations will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the understanding of microstent positioning and its effects on intraocular pressure, leading to better surgical outcomes for glaucoma patients.
How similar studies have performed: While this study focuses on specific outcomes related to microstent positioning, similar observational studies have shown promise in understanding surgical outcomes in glaucoma treatment.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Any adult glaucoma patient (age 18+) who underwent Hydrus microstent or iStent Inject placement at the Moran Eye Center. Exclusion Criteria: * Any patient who subsequently had to have their stent removed for any reason, any patient with a history of trauma to the anterior segment or reconstruction altering typical anatomy.
Where this trial is running
Murray, Utah
- Moran Eye Center — Murray, Utah, United States (Recruiting)
Study contacts
- Principal investigator: Rachel Simpson, MD — Moran Eye Center
- Study coordinator: Rachel Simpson, MD
- Email: Rachel.Simpson@hsc.utah.edu
- Phone: 480-388-9038
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.